The Globe and Mail reports in its Friday, Jan. 26, edition that BMO Nesbitt Burns analyst Tom MacKinnon expects few surprises from fourth quarter earnings season in Canada's insurance sector. The Globe's David Leeder writes in the Eye On Equities column that Mr. MacKinnon says in a note: "We expect no surprises, with Q4/23E core/base/underlying EPS estimates generally in line with consensus. MTM impacts that account for a large part of the differences between core/underlying/base EPS and reported EPS are expected to be small for Q4/23, as the MTM impact of Q4/23 favourable equity markets help offset a portion of the once again likely lower than expected ALDA/private NFI asset returns. We continue to believe organic capital generation is a comprehensive KPI for lifecos, especially under IFRS 17 (IFRS 17 earnings are not representative of organic capital generation)." Mr. MacKinnon continues to rate Great-West Lifeco "market perform." Mr. MacKinnon boosted his share target by $2 to $44. Analysts on average target the shares at $43. The Globe reported on July 23 that CIBC's Paul Holden had cut Great-West to "neutral" from "outperformer." It was then worth $39.95.